David W. Threadgill

David W. Threadgill

Auto-generated profile, based on publicly available information

David W. Threadgill

Texas A&M University

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 1995 in Science
Verified
Journal Article
Closed access
PDF file
DTDavid W. Threadgill
David W. Threadgill
ADAndrzej A. Dlugosz
Andrzej A. Dlugosz
LHLaura A. Hansen
Laura A. Hansen
TTTamar Tennenbaum
Tamar Tennenbaum
ULUlrike Lichti
Ulrike Lichti
AEAl. Et
Al. Et
Gene targeting was used to create a null allele at the epidermal growth factor receptor locus ( Egfr ). The phenotype was dependent on genetic background. EGFR deficiency on a CF-1 background resulted in peri-implantation death due to degeneration of the inner cell mass. On a 129/Sv background, homozygous mutants died at mid-gestation due to placental defects; on a CD-1 background, the mutants lived for up to 3 weeks and showed abnormalities in skin, kidney, brain, liver, and gastrointestinal tract. The multiple abnormalities associated with EGFR deficiency indicate that the receptor is involved in a wide range of cellular activities.

10 January 2007 in Behavioural Brain Research
Verified
Journal Article
Closed access
SMSheryl S Moy
Sheryl S Moy
JNJessica J Nadler
Jessica J Nadler
NYNancy B Young
Nancy B Young
APAntonio Perez
Antonio Perez
LHL Paige Holloway
L Paige Holloway
JCJacqueline N Crawley
Jacqueline N Crawley

13 February 2005 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ECElissa J Chesler
Elissa J Chesler
LLLu Lu
Lu Lu
SSSiming Shou
Siming Shou
YQYanhua Qu
Yanhua Qu
JGJing Gu
Jing Gu
RWRobert W Williams
Robert W Williams

1 December 2014 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
DDDallas R. Donohoe
Dallas R. Donohoe
DHDarcy Holley
Darcy Holley
LCLeonard B. Collins
Leonard B. Collins
SMStephanie A. Montgomery
Stephanie A. Montgomery
AWAlan C. Whitmore
Alan C. Whitmore
SBScott J. Bultman
Scott J. Bultman
Whether dietary fiber protects against colorectal cancer is controversial because of conflicting results from human epidemiologic studies. However, these studies and mouse models of colorectal cancer have not controlled the composition of gut microbiota, which ferment fiber into short-chain fatty acids such as butyrate. Butyrate is noteworthy because it has energetic and epigenetic functions in colonocytes and tumor-suppressive properties in colorectal cancer cell lines. We used gnotobiotic mouse models colonized with wild-type or mutant strains of a butyrate-producing bacterium to demonstrate that fiber does have a potent tumor-suppressive effect but in a microbiota- and butyrate-dependent manner. Furthermore, due to the Warburg effect, butyrate was metabolized less in tumors where it accumulated and functioned as a histone deacetylase (HDAC) inhibitor to stimulate histone acetylation and affect apoptosis and cell proliferation. To support the relevance of this mechanism in human cancer, we demonstrate that butyrate and histone-acetylation levels are elevated in colorectal adenocarcinomas compared with normal colonic tissues. Significance: These results, which link diet and microbiota to a tumor-suppressive metabolite, provide insight into conflicting epidemiologic findings and suggest that probiotic/prebiotic strategies can modulate an endogenous HDAC inhibitor for anticancer chemoprevention without the adverse effects associated with synthetic HDAC inhibitors used in chemotherapy. Cancer Discov; 4(12); 1387–97. ©2014 AACR. See related commentary by Sebastián and Mostoslavsky, p. 1368 This article is highlighted in the In This Issue feature, p. 1355

5 July 2007 in Genome Biology
Verified
Journal Article
Open access
PDF file
SKSergio Kaiser
Sergio Kaiser
YPYoung-Kyu Park
Young-Kyu Park
JFJeffrey L Franklin
Jeffrey L Franklin
RHRichard B Halberg
Richard B Halberg
MYMing Yu
Ming Yu
Bruce AronowBruce Aronow
Bruce Aronow
Background: The expression of carcino-embryonic antigen by colorectal cancer is an example of oncogenic activation of embryonic gene expression. Hypothesizing that oncogenesis-recapitulating-ontogenesis may represent a broad programmatic commitment, we compared gene expression patterns of human colorectal cancers (CRCs) and mouse colon tumor models to those of mouse colon development embryonic days 13.5-18.5. Results: We report here that 39 colon tumors from four independent mouse models and 100 human CRCs encompassing all clinical stages shared a striking recapitulation of embryonic colon gene expression. Compared to normal adult colon, all mouse and human tumors over-expressed a large cluster of genes highly enriched for functional association to the control of cell cycle progression, proliferation, and migration, including those encoding MYC, AKT2, PLK1 and SPARC. Mouse tumors positive for nuclear β-catenin shifted the shared embryonic pattern to that of early development. Human and mouse tumors differed from normal embryonic colon by their loss of expression modules enriched for tumor suppressors (EDNRB, HSPE, KIT and LSP1). Human CRC adenocarcinomas lost an additional suppressor module (IGFBP4, MAP4K1, PDGFRA, STAB1 and WNT4). Many human tumor samples also gained expression of a coordinately regulated module associated with advanced malignancy (ABCC1, FOXO3A, LIF, PIK3R1, PRNP, TNC, TIMP3 and VEGF). Conclusion: Cross-species, developmental, and multi-model gene expression patterning comparisons provide an integrated and versatile framework for definition of transcriptional programs associated with oncogenesis. This approach also provides a general method for identifying pattern-specific biomarkers and therapeutic targets. This delineation and categorization of developmental and non-developmental activator and suppressor gene modules can thus facilitate the formulation of sophisticated hypotheses to evaluate potential synergistic effects of targeting within- and between-modules for next-generation combinatorial therapeutics and improved mouse models.

15 March 2011 in Genome Research
Verified
Journal Article
Open access
PDF file
DADavid L. Aylor
David L. Aylor
WVWilliam Valdar
William Valdar
WFWendy Foulds-Mathes
Wendy Foulds-Mathes
RBRyan J. Buus
Ryan J. Buus
RVRicardo A. Verdugo
Ricardo A. Verdugo
GCGary A. Churchill
Gary A. Churchill
The Collaborative Cross (CC) is a mouse recombinant inbred strain panel that is being developed as a resource for mammalian systems genetics. Here we describe an experiment that uses partially inbred CC lines to evaluate the genetic properties and utility of this emerging resource. Genome-wide analysis of the incipient strains reveals high genetic diversity, balanced allele frequencies, and dense, evenly distributed recombination sites—all ideal qualities for a systems genetics resource. We map discrete, complex, and biomolecular traits and contrast two quantitative trait locus (QTL) mapping approaches. Analysis based on inferred haplotypes improves power, reduces false discovery, and provides information to identify and prioritize candidate genes that is unique to multifounder crosses like the CC. The number of expression QTLs discovered here exceeds all previous efforts at eQTL mapping in mice, and we map local eQTL at 1-Mb resolution. We demonstrate that the genetic diversity of the CC, which derives from random mixing of eight founder strains, results in high phenotypic diversity and enhances our ability to map causative loci underlying complex disease-related traits.